Cargando…
Emerging avenues in immunotherapy for the management of malignant pleural mesothelioma
BACKGROUND: The role of immunotherapy in cancer is now well-established, and therapeutic options such as checkpoint inhibitors are increasingly being approved in many cancers such as non-small cell lung cancer (NSCLC). Malignant pleural mesothelioma (MPM) is a rare orphan disease associated with pri...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8097826/ https://www.ncbi.nlm.nih.gov/pubmed/33952230 http://dx.doi.org/10.1186/s12890-021-01513-7 |